New Delhi: Citing that the proposed study protocol of Esomeprazole Dual Release GastroResistant Tablets 80mg does not address all the aims of the phase IV clinical trial, the Subject Expert Committee ...

Background: We investigated the potential interactions between esomeprazole and a non-selective nonsteroidal anti-inflammatory drug (NSAID; naproxen) or a cyclo-oxygenase (COX)-2-selective NSAID ...

Dose registered for erosive esophagitis and gastroesophageal reflux disease. iv.: Intravenous; NA: Nonavailable. Alex Mejia, MD, Department of Pharmacology and Experimental Therapeutics ...

Lactate has emerged as a key regulator in the tumor microenvironment (TME), influencing both tumor progression and immune dynamics. As a byproduct of aerobic glycolysis, lactate satisfies the ...

In the United States, more than seven million people seek emergency care for chest pain each year. However, the vast majority of these cases are not caused by a heart or lung condition. Tightness in ...